Literature DB >> 17804679

Microvascular and C-fiber function in diabetic charcot neuroarthropathy and diabetic peripheral neuropathy.

Neil Baker1, Alistair Green, Singhan Krishnan, Gerry Rayman.   

Abstract

OBJECTIVE: Sympathetic denervation and hyperemia are implicated in the pathogenesis of Charcot neuroarthropathy (CN) but are also features of diabetic peripheral neuropathy (DPN). Differences in these physiological parameters were sought by determining C-fiber function (laser Doppler imager [LDI]flare technique) and maximum microvascular hyperemia (MMH) in 13 subjects with diabetic CN (DCN), 10 subjects with DPN, and 10 healthy control subjects. Additionally, unaffected limbs of the nine DCN subjects with unilateral CN (UCN) were studied to determine whether any observed differences precede CN.
RESULTS: LDIflare area was reduced in DPN (mean +/- SD 1.41 +/- 0.51 cm(2)) and DCN (1.42 +/- 0.37) groups compared with the healthy control group (5.24 +/- 1.33; P < 0.0001). MMH was higher in DCN (432 +/- 88 PU [perfusion units]) than in DPN (262 +/- 71; P = 0.001) subjects but lower than in the control group (564 +/- 112; P < 0.01). LDIflare area and MMH were similar in the UCN and DCN groups.
CONCLUSIONS: C-fiber function is equally impaired in neuropathic patients with and without CN; however, a higher MMH distinguishes those with CN. Unaffected and affected limbs of those with unilateral CN have the same neurovascular abnormalities, suggesting that these abnormalities precede CN and are not a result of CN.

Entities:  

Mesh:

Year:  2007        PMID: 17804679     DOI: 10.2337/dc07-1063

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

Review 1.  Nociception at the diabetic foot, an uncharted territory.

Authors:  Ernst A Chantelau
Journal:  World J Diabetes       Date:  2015-04-15

Review 2.  Microvascular dysfunction in the context of diabetic neuropathy.

Authors:  Alin Stirban
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

3.  Non-contrast MRI perfusion angiosome in diabetic feet.

Authors:  Jie Zheng; Mary K Hastings; David Muccigross; Zhaoyang Fan; Fabao Gao; John Curci; Charles F Hildebolt; Michael J Mueller
Journal:  Eur Radiol       Date:  2014-08-07       Impact factor: 5.315

4.  The Charcot foot in diabetes.

Authors:  Lee C Rogers; Robert G Frykberg; David G Armstrong; Andrew J M Boulton; Michael Edmonds; Georges Ha Van; Agnes Hartemann; Frances Game; William Jeffcoate; Alexandra Jirkovska; Edward Jude; Stephan Morbach; William B Morrison; Michael Pinzur; Dario Pitocco; Lee Sanders; Dane K Wukich; Luigi Uccioli
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112

Review 5.  Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis.

Authors:  Sean Michael Lanting; Tsz Long Chan; Sarah Louise Casey; Benjamin John Peterson; Vivienne Helaine Chuter
Journal:  J Foot Ankle Res       Date:  2022-03-01       Impact factor: 2.303

Review 6.  [Pathophysiology and MRI Findings of Infectious Spondylitis and the Differential Diagnosis].

Authors:  Sunjin Ryu; Yeo Ju Kim; Seunghun Lee; Jeongah Ryu; Sunghoon Park; Jung Ui Hong
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-11-30

7.  Pressure pain perception in the diabetic Charcot foot: facts and hypotheses.

Authors:  Ernst A Chantelau; Tobias Wienemann
Journal:  Diabet Foot Ankle       Date:  2013-05-21

8.  An overview of the Charcot foot pathophysiology.

Authors:  Gökhan Kaynak; Olgar Birsel; Mehmet Fatih Güven; Tahir Oğüt
Journal:  Diabet Foot Ankle       Date:  2013-08-02

9.  Management of autonomic dysreflexia associated with Charcot spinal arthropathy in a patient with complete spinal cord injury: Case report and review of the literature.

Authors:  Justin L Gibson; Shawn M Vuong; Robert J Bohinski
Journal:  Surg Neurol Int       Date:  2018-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.